Positive Recommendations made by the PBAC - April 2008
|
Drug and Form |
Drug Use and Type |
Listing Requested |
PBAC Recommendation |
|---|---|---|---|
| INFLUENZA VACCINE, injection (trivalent) containing A/Solomon Islands/3/2006, A/Brisbane/10/2007
and B//Florida/4/2006 like strains, 0.25 mL pre-filled syringe, Fluvax Junior® CSL
Biotherapies Pty Ltd Minor submission |
Influenza vaccination | Restricted benefit listing for children up to 35 months of age at increased risk of adverse consequences from infections of the lower respiratory tract. | The PBAC recommended listing of this additional form of influenza vaccine suitable for children up to 35 months of age. |
| MELOXICAM, tablets, 7.5 mg and 15 mg, Chem mart Meloxicam®, Chem mart Pty Ltd, GenRx
Meloxicam®, Apotex Pty Ltd, Meloxibell®, Meloxicam-GA®, Bellwether Pharma Pty Ltd,
Meloxicam Ranbaxy®, Ranbaxy Australia Pty Ltd, Meloxicam Sandoz®, Sandoz Pty Ltd,
Movalis 7.5® and Movalis 15®, Arrow Pharmaceuticals Pty Ltd, Moxicam 7.5® and Moxicam
15®, Alphapharm Pty Ltd, Pharmacor Meloxicam 7.5® and Pharmacor Melxoicam 15®, Pharmacor
Pty Ltd, Terry White Chemists Meloxicam 7.5 mg® and Terry White Chemists Meloxicam
15 mg®, Terry White Chemists, Mobic®, Boehringer Ingelheim Pty Ltd, capsules, 7.5
mg and 15 mg, Mobic® Boehringer Ingelheim Pty Ltd Minor submission |
Arthritis | Restricted benefit listing for the symptomatic treatment of rheumatoid arthritis |
The PBAC recommended extending the listing of meloxicam to include the symptomatic treatment of rheumatoid arthritis. |
